[1] Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome(APS)[J]. J Thromp Haemost, 2006, 4:295-306.
[2] Sourander P, Wålinder J. Hereditary multi-infarct dementia.Morphological and clinical studies of a new disease[J]. Acta Neuropathol, 1977, 39:247-254.
[3] Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG. Cadasil[J]. Lancet Neurol, 2009, 8:643-653.
[4] Di Donato I, Bianchi S, De Stefano N, Dichgans M, Dotti MT, Duering M, Jouvent E, Korczyn AD, Lesnik-Oberstein SA, Malandrini A, Markus HS, Pantoni L, Penco S, Rufa A, Sinanovic O, Stojanov D, Federico A. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) as a model of small vessel disease:update on clinical, diagnostic, and management aspects[J]. BMC Med, 2017, 15:41.
[5] Wang Z, Yuan Y, Zhang W, Lv H, Hong D, Chen B, Liu Y, Luan X, Xie S, Wu S. NOTCH3 mutations and clinical features in 33 mainland Chinese families with CADASIL[J]. J Neurol Neurosurg Psychiatry, 2011, 82:534-539.
[6] Wollenweber FA, Hanecker P, Bayer-Karpinska A, Malik R, Bäzner H, Moreton F, Muir KW, Müller S, Giese A, Opherk C, Dichgans M, Haffner C, Duering M. Cysteine-sparing CADASIL mutations in NOTCH3 show proaggregatory properties in vitro[J]. Stroke, 2015, 46:786-792.
[7] Joutel A, Andreux F, Gaulis S, DomengaV, Cecillon M, Battail N, Piga N, Chapon F, Godfrain C, Tournier-Lasserve E. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients[J]. J Clin Invest, 2000, 105:597-605.
[8] Guey S, Mawet J, Hervé D, Duering M, Godin O, Jouvent E, Opherk C, Alili N, Dichgans M, Chabriat H. Prevalence and characteristics of migraine in CADASIL[J]. Cephalalgia, 2016, 36:1038-1047.
[9] Dichgans M, Mayer M, Uttner I, Brüning R, Müller-Höcker J, Rungger G, Ebke M, Klockgether T, Gasser T. The phenotypic spectrum of CADASIL:clinical findings in 102 cases[J]. Ann Neurol, 1998, 44:731-739.
[10] Choi EJ, Choi CG, Kim JS. Large cerebral artery involvement in CADASIL[J]. Neurology, 2005, 65:1322-1324.
[11] Santa Y, Uyama E, Chui DH, Arima M, Kotorii S, Takahashi K, Tabira T. Genetic, clinical and pathological studies of CADASIL in Japan:a partial contribution of Notch3 mutations and implications of smooth muscle cell degeneration for the pathogenesis[J]. J Neurol Sci, 2003, 212:79-84.
[12] Yin X, Wu D, Wan J, Yan S, Lou M, Zhao G, Zhang B.Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy:phenotypic and mutational spectrum in patients from mainland China[J]. Int J Neurosci, 2015, 125:585-592.
[13] Kang HG, Kim JS. Intracranial arterial disease in CADASIL patients[J]. J Neurol Sci, 2015, 359:347-350.
[14] Choi JC, Song SK, Lee JS, Kang SY, Kang JH. Diversity of stroke presentation in CADASIL:study from patients harboring the predominant NOTCH3 mutation R544C[J]. J Stroke Cerebrovasc Dis, 2013, 22:126-131.
[15] Auer DP, Pütz B, Gössl C, Elbel G, Gasser T, Dichgans M.Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy:MR imaging study with statistical parametric group comparison[J]. Radiology, 2001, 218:443-451.
[16] Puy L, De Guio F, Godin O, Duering M, Dichgans M, Chabriat H, Jouvent E. Cerebral microbleeds and the risk of incident ischemic stroke in CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy)[J]. Stroke, 2017, 48:2699-2703.
[17] Bersano A, Bedini G, Markus HS, Vitali P, Colli-Tibaldi E, Taroni F, Gellera C, Baratta S, Mosca L, Carrera P, Ferrari M, Cereda C, Grieco G, Lanfranconi S, Mazucchelli F, Zarcone D, De Lodovici ML, Bono G, Boncoraglio GB, Parati EA, Calloni MV, Perrone P, Bordo BM, Motto C, Agostoni E, Pezzini A, Padovani A, Micieli G, Cavallini A, Molini G, Sasanelli F,Sessa M, Comi G, Checcarelli N, Carmerlingo M, Corato M, Marcheselli S, Fusi L, Grampa G, Uccellini D, Beretta S, Ferrarese C, Incorvaia B, Tadeo CS, Adobbati L, Silani V, Faragò G, Trobia N, Grond-Ginsbach C, Candelise L;Lombardia GENS-Group. The role of clinical and neuroimaging features in the diagnosis of CADASIL[J]. J Neurol, 2018, 265:2934-2943.
[18] Zhuang XB, Wang WF, Shan GZ, Chen TZ, Jiang GS, Yang XF.The significance of the serum ACA-IgG, IL-17 and hsCRP concentration in ischemic stroke of young adults[J]. Zhonghua Zhen Duan Xue Dian Zi Za Zhi, 2017, 5:51-54.[庄献博, 王未飞, 单广振, 陈团芝, 姜桂生, 杨霞峰. 青中年缺血性脑卒中患者血清抗心磷脂抗体免疫球蛋白G、白细胞介素-17、超敏C反应蛋白水平变化的意义[J]. 中华诊断学电子杂志, 2017, 5:51-54.]